Key facts
- Notable investors include Fan Zhuo Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Kaoyin Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Kaoyin Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kaoyin Bio
Manufacturer of innovative medical dressings and bioactive materials designed to enhance clinical treatment performance and patient safety. The company engages in pharmaceutical-related research and development while also providing molecular point-of-care testing (POCT) in vitro diagnostic solutions, enabling healthcare providers to access advanced wound care products and rapid, accurate diagnostic services.
- Sector
- Healthcare
- HQ
- Taizhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Kaoyin Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kaoyin Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kaoyin Bio in its N-PORT filings yet. We sweep new filings monthly.